Novo Nordisk NASH Alzheimer's Commercial Strategy 2022

Novo Nordisk presentation outlining commercial execution strategy and innovation focus for NASH and Alzheimer's disease. Includes strategic aspirations for 2025 covering diabetes, obesity, rare disease, and chronic disease portfolios with targets for global market share, sales growth, and operational efficiency.